The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8.75
Bid: 8.50
Ask: 9.00
Change: 0.81 (10.20%)
Spread: 0.50 (5.882%)
Open: 8.25
High: 8.75
Low: 8.25
Prev. Close: 7.94
TEK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

MicroSalt files New Patent to Improve Baked Goods

7 Sep 2023 07:00

RNS Number : 6201L
Tekcapital plc
07 September 2023
 

This is a Reach announcement and the information contained is not considered to be material or to have a significant impact on management's expectations of the Company's performance. Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on Reach.

7 September 2023

Tekcapital Plc

("Tekcapital")

 

MicroSalt® files New Patent to Improve Baked Goods

 

Tekcapital Plc (AIM: TEK) the UK intellectual property investment group focused on creating valuable products that can improve people's lives, is pleased to announce that its portfolio company Microsalt Ltd ("Microsalt") has filed a new patent application (# 63/580,590) entitled "Compositions and methods for reduced leavening time and sodium content in doughs comprising micron-sized salt particles adhered to a carrier," to improve baked goods.

Highlights:

· MicroSalt has recently demonstrated the successful utilisation of its proprietary low-sodium technology with a new recipe for use in baked goods

· There is significant global demand for reducing sodium in a wide variety of baked goods

· MicroSalt believes its new low sodium recipe reduces both sodium content and baking time for baked goods, enabling an improved nutritional profile coupled with a more sustainable and cost-effective production process

Rick Guiney, CEO of MicroSalt®, commented:

"We are very excited about our new invention which we believe enables the production of baked goods quicker, less expensively, and with reduced sodium. The bread market is extremely compelling for us, with global volumes expected to reach 216.7bn kg by 2028[1]. Our ability to not only reduce sodium but to enable a more efficient production process could be a watershed moment in the fight against excess sodium consumption, and we have already seen a high level of interest from one of the world's largest food companies."

 

Market Size

According to Statista the global bread market is estimated to be valued at US$0.5tn in 2023 and is expected to grow annually by 6.83% (CAGR 2023-2028).[2] MicroSalt believe that its new technology can be utilised on a wide variety of baked products to significantly reduce their current sodium concentrations. Potential product applications are listed below.

 

Common Types of Bread (2 slices/serving)[3]

Sodium Content (mg) per serving

 White Bread

340

 Whole Wheat Bread

276

 Rye Bread

422

 Multigrain Bread

253

 Sourdough Bread

304

 Mixed Grain Bread

253

 Marble Rye and Pumpernickel Bread

346

 White with Whole Wheat Swirl Bread

314

 

Reduced Calorie Bread (2 slices/serving)

 Wheat Bread

235

 White Bread

208

 Multigrain Bread

158

 Rye Bread

211

 

Other Bread Varieties (2 slices/serving)

 Cracked Wheat Bread

269

 Italian Bread

234

 Oatmeal Bread

323

 Raisin Bread

203

 Wheat Bran Bread

350

Rolls and Buns (1 roll/serving)

 

 Dinner Roll

146

 Wheat Dinner Roll

95

 Egg Dinner Roll

191

 French Roll

231

 Hamburger or Hotdog Roll

206

 Mixed Grain Hamburger or Hotdog Roll

197

 

According to the U.S. Food and Drug Administration ("FDA"), 2,300 mg/day is the maximum recommended sodium consumption for healthy adults.[4] By reference, a single serving of white bread currently exceeds 14% of the daily maximum recommended consumption of sodium.

 

About MicroSalt

MicroSalt is dedicated to innovating food technology solutions that enable people to live longer, healthier, and happier lives. Its patented low-sodium salt delivers natural salt with approximately 50% less sodium and may be used by both consumers and food manufacturers who wish to decrease the amount of sodium in their food. MicroSalt is 100% natural, non-GMO, gluten free, Kosher and contains no potassium chloride. To learn more about MicroSalt and MicroSalt® products, please visit www.microsalt.co.

Tekcapital owns 97% of the share capital of MicroSalt Ltd. and 6,034,683 shares (78%) of MicroSalt Inc., its U.S. subsidiary.

About Tekcapital plc

Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.

 

LEI: 213800GOJTOV19FIFZ85

For further information, please contact:

Tekcapital Plc 

 Via Flagstaff IR

Clifford M. Gross, Ph.D. 

SP Angel Corporate Finance LLP (Nominated Adviser and Broker)

+44 (0) 20 3470 0470 

Richard Morrison / Charlie Bouverat (Corporate Finance)

Rob Rees (Corporate Broking)

 

Flagstaff Strategic and Investor Communications

Tim Thompson/Andrea Seymour/Fergus Mellon

microsalt@flagstaffcomms.com

 

+44 (0)207 129 1474

This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving MicroSalt and/or Tekcapital that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of MicroSalt and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of MicroSalt or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither MicroSalt nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.


[1] https://www.statista.com/outlook/cmo/food/bread-cereal-products/bread/worldwide#:~:text=In%20the%20Bread%20market%2C%20volume,growth%20of%203.9%25%20in%202024.

 

[2] https://www.statista.com/outlook/cmo/food/bread-cereal-products/bread/worldwide#:~:text=Revenue%20in%20the%20Bread%20market,US%2472bn%20in%202023).

 

[3] https://www.fatsecret.com/calories-nutrition/food/bread/sodium

 

[4] https://www.fda.gov/media/84261/download#:~:text=Americans%20eat%20on%20average%20about,1%20teaspoon%20of%20table%20salt

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRASSWFMMEDSESU
Date   Source Headline
20th May 20201:51 pmRNSNotification Of Major Shareholding
19th May 202012:07 pmRNSResult of GM and Completion of Fundraise
6th May 20207:00 amRNSFinal Results
1st May 20207:00 amRNSConditional Placing to raise £925,000
29th Apr 202011:05 amRNSSecond Price Monitoring Extn
29th Apr 202011:00 amRNSPrice Monitoring Extension
24th Apr 20207:00 amRNSLucyd expands online presence to Walmart.com
21st Apr 20202:35 pmRNSCorrection : Total Voting Rights
20th Apr 202011:05 amRNSSecond Price Monitoring Extn
20th Apr 202011:00 amRNSPrice Monitoring Extension
20th Apr 20207:00 amRNSMarket Research Report: Belluscura plc
14th Apr 20202:06 pmRNSSecond Price Monitoring Extn
14th Apr 20202:01 pmRNSPrice Monitoring Extension
14th Apr 202011:06 amRNSSecond Price Monitoring Extn
14th Apr 202011:00 amRNSPrice Monitoring Extension
9th Apr 20203:27 pmRNSHolding(s) in Company
8th Apr 20207:00 amRNSPortfolio Company Update : Guident
2nd Apr 20207:00 amRNSMexico adopts new Sodium reduction guidelines
30th Mar 20202:54 pmRNSHolding(s) in Company
27th Mar 202012:45 pmRNSHolding(s) in Company
26th Mar 20208:00 amRNSPortfolio Company Update:
26th Mar 20207:00 amRNSPortfolio Company Update: Lucyd
24th Mar 20207:00 amRNSSalarius confirms store roll out
23rd Mar 20202:59 pmRNSPortfolio Company Update
23rd Mar 202010:56 amRNSHolding(s) in Company
16th Mar 20209:15 amRNSBelluscura plc filing of a patent
4th Mar 20207:00 amRNSSalarius secures contract sales partner
2nd Mar 20207:00 amRNSSalarius North American distribution agreement
28th Feb 20207:00 amRNSTotal Voting Rights
12th Feb 20203:09 pmRNSHolding(s) in Company
10th Feb 20202:12 pmRNSHolding(s) in Company
10th Feb 20207:00 amRNSStrategy/Company/Ops Update
7th Feb 20204:03 pmRNSHolding(s) in Company
6th Feb 202012:45 pmRNSPlacing to raise £740,000
24th Jan 20207:00 amRNSSalarius new major food contract
20th Jan 20207:00 amRNSLucyd launch of new bluetooth-enabled Glasses
16th Jan 20207:00 amRNSExhibit At AUTM 2020
7th Jan 20207:00 amRNSAppointment of Director
17th Dec 20197:00 amRNSPortfolio Company Update: Lucyd
12th Dec 20197:00 amRNSPortfolio Company Update
2nd Dec 20191:09 pmRNSBoard Changes
1st Nov 20197:00 amRNSChange of Adviser
16th Oct 20197:00 amRNSPortfolio Company Update
16th Sep 20199:07 amRNSShare Options
2nd Sep 20197:00 amRNSPortfolio Company Update
22nd Aug 20197:00 amRNSHalf-year Report
15th Aug 20197:00 amRNSPortfolio Update: Lucyd Launches Sherman Shades
12th Aug 20197:00 amRNSSalarius Files Additional Patent for MicroSalt®
6th Aug 20197:00 amRNSBelluscura raises £750,000 of additional funding
5th Aug 20193:21 pmRNSHolding(s) in Company - Replacement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.